The automation giant sees its combination of digital technologies—including AI, digital twins, digital thread and SDA—as the ...

Access Holdings Plc and Coronation Group hosted a private reception at Tate Modern, London, to celebrate the enduring legacy ...

Board of Directors has resolved to launch a new stock option program for Nightingale Health’s or its group companies’ employees or other key persons. The purpose of Nightingale Health’s stock option ...

New opportunities connect healthcare innovators with more than 1,000 investors, healthcare leaders and potential partn ...

The 230,000 sq ft of newly vacant space at the Humber Enterprise Park, on the outskirts of Hull, is being marketed by Knight ...

Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), a global multi-brand beauty and wellness platform, today announced that the U.S. Food and Drug Administration (“FDA”) has approved Obagi ...

June 2026 Enhertu approved in the EU as first tumour agnostic HER2-directed therapy and antibody drug conjugate for patients with previously treated HER2-positive metastatic solid tumours Based on ...

Ocugen has no product revenue, remains loss-making, and the convertible notes add debt burden and potential share dilution.

DNA Damage Response (“DDR”) inhibitors, a category of drugs that work by blocking cancer cells' capacity to fix their own damaged DNA, are growing well beyond the poly ADP ribose polymerase (“PARP”) ...

Our experts relay a complete BetMGM sportsbook review of the experience awaiting online sports bettors on one of America's most popular betting apps in 2026.

Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an increasingly intertwined human-machine model moves closer to adoption in real-world ...

How smarter, more user-focused display technology can better support work and play.